Asthma drug shows promise in slowing diabetic kidney damage
NCT ID NCT07022418
Summary
This study is testing whether adding formoterol, a medication commonly used for asthma, to standard care can help people with diabetic kidney disease. About 120 participants will be randomly assigned to receive either formoterol plus their usual care or just their usual care alone for 36 weeks. The main goals are to see if the treatment is practical and safe, and to gather early evidence on whether it reduces protein in urine and slows the decline of kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.